DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Onapristone
Onapristone
OECD Environment Health and Safety Publications Series on Testing and Assessment No
2019 AAPLOG Position Statement on Abortion Pill Reversal
The Clinical Efficacy of Progesterone Antagonists in Breast Cancer ------ .__..__
527.Full.Pdf
The Pure Progesterone Receptor (PR) Antagonist Onapristone Enhances
Onapristone Extended Release: Safety Evaluation from Phase I–II Studies with an Emphasis on Hepatotoxicity
Spontaneous Regression of an Asymptomatic Meningioma Associated with Discontinuation of Progesterone Agonist Administration —Case Report—
Stembook 2018.Pdf
2018 Medicines in Development for Cancer
(12) Patent Application Publication (10) Pub. No.: US 2016/0166583 A1 Zukiwski Et Al
Methods of Contraception Verfahren Zur Empfängnisverhütung Methodes De Contraception
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Antiprogestins in Breast Cancer Treatment: Are We Ready?
Oral Contraceptive Pills
Effect of Medroxyprogesterone Acetate on Sex Hormone- Binding Globulin Mrna Expression in the Human Endometrial Cancer Cell Line Ishikawa
Customs Tariff - Schedule Xxi - 1
Receptor Blockers — General Aspects with Respect to Their Use in Domestic
(12) United States Patent (10) Patent N0.: US 6,506,390 B2 Bennink Et Al
Top View
Wo 2007/044693 A2
Hormonal Therapy for Endometriosis: from Molecular Research to Bedside
WO 2012/121767 Al 13 September 2012 (13.09.2012)
EMAS Position Statement: Management of Uterine Fibroids
An Update on Developments in Female Hormonal Contraception
Effect of Medroxyprogesterone Acetate on Sex Hormone- Binding Globulin Mrna Expression in the Human Endometrial Cancer Cell Line Ishikawa
Harmonized Tariff Schedule of the United States (2006) (Rev
Inhibiting Nuclear Phospho-Progesterone Receptor
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Endometriosis: the Role of Pharmacotherapy
Progesterone Action in Breast, Uterine, and Ovarian Cancers
Tamoxifen for Treatment of Abnormal Uterine Bleeding in Etonorgstrel Implant Users: a Randomized Clinical Trial
Inhibiting Nuclear Phospho-Progesterone Receptor
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
Failure of Two Progesterone Antagonists, Mifepristone and Onapristone, to Affect Luteal Activity in Lactating Rats P
Bioinformatics Analysis of Essential Genes in NF1 and CDKN2A Null Cancer Cell Lines
Anti-Proliferative Effects of Progesterone Antagonists in the Primate Endometrium: a Potential Role for the Androgen Receptor
1111111111111111111Imnumu
Research.Pdf
Steroids Receptors
Residual Ovarian Activity During Oral Steroid Contraception
Endometriosis (Booklet)